Skip to main content
OpenTrials

Clinical trial condition

Metastatic Malignant Solid Neoplasm

Explore clinical trials studying Metastatic Malignant Solid Neoplasm. Study availability and eligibility vary by location and protocol.

137 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Malignant Solid Neoplasm trial results

Completed

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

NCT04889144

Conditions
Behavior, Communication, Locally Advanced Malignant Solid Neoplasm, +6 more
Locations
  • Weill Cornell Medicine New York, United States
  • UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Confluence Health Wenatchee, Washington, United States
View Trial Details
Completed

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

NCT03080883

Conditions
Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +28 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Cleveland Clinic-Weston Weston, Florida, United States
View all 32 locations
View Trial Details
Completed

Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

NCT00576654

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

NCT02070549

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Solid Neoplasm, +6 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02503709

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +5 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Completed

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

NCT01902173

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +25 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • California Pacific Medical Center-Pacific Campus San Francisco, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

NCT02143401

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +34 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View Trial Details

Related conditions